75 related articles for article (PubMed ID: 22334590)
1. Therapeutic efficacy of CEP-33779, a novel selective JAK2 inhibitor, in a mouse model of colitis-induced colorectal cancer.
Seavey MM; Lu LD; Stump KL; Wallace NH; Hockeimer W; O'Kane TM; Ruggeri BA; Dobrzanski P
Mol Cancer Ther; 2012 Apr; 11(4):984-93. PubMed ID: 22334590
[TBL] [Abstract][Full Text] [Related]
2. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
Lu LD; Stump KL; Wallace NH; Dobrzanski P; Serdikoff C; Gingrich DE; Dugan BJ; Angeles TS; Albom MS; Mason JL; Ator MA; Dorsey BD; Ruggeri BA; Seavey MM
J Immunol; 2011 Oct; 187(7):3840-53. PubMed ID: 21880982
[TBL] [Abstract][Full Text] [Related]
3. A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis.
Stump KL; Lu LD; Dobrzanski P; Serdikoff C; Gingrich DE; Dugan BJ; Angeles TS; Albom MS; Ator MA; Dorsey BD; Ruggeri BA; Seavey MM
Arthritis Res Ther; 2011 Apr; 13(2):R68. PubMed ID: 21510883
[TBL] [Abstract][Full Text] [Related]
4. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.
Cheon JH; Kim KS; Yadav DK; Kim M; Kim HS; Yoon S
Biochem Biophys Res Commun; 2017 Sep; 490(4):1176-1182. PubMed ID: 28669723
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
Zhang T; Jiang B; Zou ST; Liu F; Hua D
World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
[TBL] [Abstract][Full Text] [Related]
6. JAK2 inhibitor CEP-33779 prevents mouse oocyte maturation
Wu C; Li R; Luo H; Xu M; Zhang X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28615348
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of sophocarpine in treating experimental colitis in mice].
Zhang JM; Zhu YB; Deng X; Wang CX; Luan SM; Chen YX
Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(15):3081-7. PubMed ID: 26677715
[TBL] [Abstract][Full Text] [Related]
8. P-gp Inhibition by XL019, a JAK2 Inhibitor, Increases Apoptosis of Vincristine-treated Resistant KBV20C Cells with Increased p21 and pH2AX Expression.
Cheon JH; Kim JY; Lee BM; Kim HS; Yoon S
Anticancer Res; 2017 Dec; 37(12):6761-6769. PubMed ID: 29187454
[TBL] [Abstract][Full Text] [Related]
9. The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3.
Lee SM; Yoon KB; Lee HJ; Kim J; Chung YK; Cho WJ; Mukai C; Choi S; Kang KW; Han SY; Ko H; Kim YC
Bioorg Med Chem; 2016 Nov; 24(21):5036-5046. PubMed ID: 27555284
[TBL] [Abstract][Full Text] [Related]
10. N6-substituted adenosine analogues, a novel class of JAK2 inhibitors, potently block STAT3 signaling in human cancer cells.
Liu P; Zhao L; Xu X; Liu F; Zhang W; Zhou C; Chen J; Pan Y; Du Y; Yang J; Wang Q
Cancer Lett; 2014 Nov; 354(1):43-57. PubMed ID: 25107644
[TBL] [Abstract][Full Text] [Related]
11. AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway.
Wang SW; Hu J; Guo QH; Zhao Y; Cheng JJ; Zhang DS; Fei Q; Li J; Sun YM
Oncol Rep; 2014 Nov; 32(5):1991-8. PubMed ID: 25216185
[TBL] [Abstract][Full Text] [Related]
12. A selective, orally bioavailable 1,2,4-triazolo[1,5-a]pyridine-based inhibitor of Janus kinase 2 for use in anticancer therapy: discovery of CEP-33779.
Dugan BJ; Gingrich DE; Mesaros EF; Milkiewicz KL; Curry MA; Zulli AL; Dobrzanski P; Serdikoff C; Jan M; Angeles TS; Albom MS; Mason JL; Aimone LD; Meyer SL; Huang Z; Wells-Knecht KJ; Ator MA; Ruggeri BA; Dorsey BD
J Med Chem; 2012 Jun; 55(11):5243-54. PubMed ID: 22594690
[TBL] [Abstract][Full Text] [Related]
13. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X
Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989
[TBL] [Abstract][Full Text] [Related]
14. Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth.
Sayyah J; Magis A; Ostrov DA; Allan RW; Braylan RC; Sayeski PP
Mol Cancer Ther; 2008 Aug; 7(8):2308-18. PubMed ID: 18723478
[TBL] [Abstract][Full Text] [Related]
15. Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2
Hu M; Xu C; Yang C; Zuo H; Chen C; Zhang D; Shi G; Wang W; Shi J; Zhang T
J Exp Clin Cancer Res; 2019 Feb; 38(1):49. PubMed ID: 30717771
[TBL] [Abstract][Full Text] [Related]
16. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.
Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q
Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
18. α7 nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2/STAT3 signaling pathway.
Fei R; Zhang Y; Wang S; Xiang T; Chen W
Oncol Rep; 2017 Nov; 38(5):2619-2628. PubMed ID: 28901507
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis.
Yang F; Jove V; Buettner R; Xin H; Wu J; Wang Y; Nam S; Xu Y; Ara T; DeClerck YA; Seeger R; Yu H; Jove R
Cancer Biol Ther; 2012 May; 13(7):534-41. PubMed ID: 22406995
[TBL] [Abstract][Full Text] [Related]
20. microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2/STAT3 and MAP3K8/ERK signaling pathways.
Wei R; Yang Q; Han B; Li Y; Yao K; Yang X; Chen Z; Yang S; Zhou J; Li M; Yu H; Yu M; Cui Q
Oncotarget; 2017 Mar; 8(10):16633-16641. PubMed ID: 28186962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
